The Influence of Anti-Platelet and Antithrombotic Treatment on the Clinical Course of Bleeding into the Lumen of Alimentary Tract Upper Segment

• Autorzy: Jarosław Matykiewicz , Stanisław Głuszek , Sławomir Szafran
• Języki publikacji: EN

Abstrakty

EN

The most frequently used drugs which may cause bleeding into the lumen of alimentary tract include: acetylsalicylic acid (ASA), ticlopidine/clopidogrel and acenocoumarol.The aim of the study was to analyze the frequency of the occurrence of bleeding into the lumen of alimentary tract upper segment (gopp) in patients taking anti-platelet drugs and oral anticoagulants, treated at the surgical department.Material and methods. The study covered a group of 164 patients treated at the Clinical Surgery Department of the Provincial Hospital in Kielce over the years 2006-2009. They were consecutive patients admitted to hospital with the initial diagnosis of bleeding into the lumen of gopp. The diagnosis was made on the basis of medical history, clinical examination and additional investigation. In all patients within 24-48 hours after the admission endoscopy of gopp was performed.Results. 164 patients with symptoms of bleeding into the lumen of gopp were treated. Among them there were 94 men (57%) as well as 70 women (43%). The average age was 61.8 years (from 23 to 91 years). In this group 24.4% (40/164) patients took drugs influencing coagulation system (acetylsalicylic acid, clopidogrel and/or acenocoumarol). In the subgroup taking the drugs mentioned above were 21 men (52.5%) and 19 women (47.5%). The average age was 73.6 years (from 48 to 91 years). Among patients taking drugs influencing hemostasis system 23 patients took ASA preparations, ticlopidine/clopidogrel - 5 patients and acenocoumarol - 12 patients. 8 patients took more than one drug, most frequently ASA and ticlopidine/clopidogrel, 1 patient took three drugs. 6 deaths were reported in the group taking drugs. Mortality rate was 15% (6/40). Among the deceased patients significantly lower (p<0.001) concentration of hemoglobin at the admission can be noticed (average concentration of Hb reached 6.1 g/dl) as well as non-interchangeably higher (p=0.13) average age of patients (average age of the deceased patients was 77.2 years). All the deceased patients were admitted to hospital with hypovolaemic shock. Results were statistically analyzed by the use of the test for comparison of two proportions and the t-Student test for the difference in expected values.Conclusions. Bleeding into the lumen of gopp induces considerable mortality, especially in patients with low hemoglobin concentration and hypotension at the admission to hospital. During the treatment of a patient with bleeding into the lumen of gopp a compromise between the risk of cardiovascular complications and the risk of death due to bleeding should be searched for.

Słowa kluczowe

EN

acetylsalicylic acid; bleeding into the lumen of alimentary tract

• Wydawca: Index Copernicus International
• Czasopismo: Polish Journal of Surgery
• Rocznik: 2010
• Tom: 82
• Numer: 12
• Strony: 651-656

Daty

wydano

2010-12-01

online

2011-02-23

Twórcy

autor

Jarosław Matykiewicz

autor

Stanisław Głuszek

autor

Sławomir Szafran

• Clinical Department for General, Oncological and Endocrinological Surgery, The Provincial Hospital in Kielce

Bibliografia

• Choudhry NK, Levin R, Avorn J: The Economic Consequences of Non-Evidence-Based Clopidogrel Use. American Heart Journal 2008; 155: 904-09.[WoS]
• Targownik LE, Leong MS: Underutilization gastroprotective strategies in aspirine users at increased risk of upper gastrointestinal complications. Aliment Pharmacol Ther 2008; 28: 88-96.[WoS]
• Laine L: Gastrointestinal bleeding with lowedose-aspirine - what's the risk ? Aliment Pharmacol Ther 2006; 24: 897-908.
• Khurram Z, Chou E, Minutello R et al.: Combination Therapy With Aspirin, Clopidogrel and Warfarin Following Coronary Stenting is Associated With a Significant Risk of Bleeding. J Invasive Cardiol 2006; 18: 162-64.
• Halls J, Dall M, Andriesi M et al.: Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ; 333: 726-29.
• Straube S, Tramer MR, Moore A Et al.: Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroeneterology 2009, www.medscape.com
• Imiela J, Opolski G, Rydzewska G i wsp.: Konsensus Grupy Roboczej powołanej przez konsultantów krajowych w dziedzinach: chorób wewnętrznych, gastroenterologii i kardiologii w sprawie zasad prewencji powikłań żołądkowojelitowych z przewodu pokarmowego w trakcie leczenia przeciwpłytkowego. Medycyna i Życie 2009; 2: 2-5.
• Laine L, Maller ES, Yu C Et al.: Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double blind trial. Gastroenterology 204; 127: 395-402.
• Karcz D: Endoskopia w chirurgii. Pol Przegl Chir 2009; 81: 1083-89.
• ACCF/ACG/AHA 2008 Expert consensus document on reducing the gastrointestinal risk of antiplatelet therapy and NSAID use. Cardiosurce 2008
• Liu A, Stupmo C: Warfarin drug interactions among older adults. Geriatrics Aging 2007; 10: 643-46.
• Sung JJY, Lau JYW, Ching JYL et al.: Continuation of low-dose aspirine therapy in peptic ulcer bleeding: A randomized trial. Ann Intern Med 2010: 152: 1-9.
• Cole BF, Logan RF, Halabi S et al.: Aspiryn for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. Journal of the National Cancer Institute 2009; 101: 256-66.
• Buksińska-Lisik M, Pasierski T: Zasady postępowania w zabiegach chirurgicznych u chorych przewlekle leczonych przeciwzakrzepowo. Pol Przegl Chir 2009; 81: 466-80.

Identyfikatory

DOI

10.2478/v10035-010-0100-3